ATRS - Antares Pharma, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts5455
Avg. Estimate-0.03-0.02-0.110.01
Low Estimate-0.04-0.04-0.12-0.11
High Estimate-0.01-0.01-0.10.18
Year Ago EPS-0.03-0.03-0.16-0.11
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts5355
Avg. Estimate15.65M13.98M56.19M87.39M
Low Estimate12.75M10.63M53.23M64M
High Estimate17.7M18.4M58.2M118.8M
Year Ago Sales14.2M12.01M52.22M56.19M
Sales Growth (year/est)10.20%16.40%7.60%55.50%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.04-0.03-0.03-0.03
EPS Actual-0.03-0.03-0.02-0.03
Difference0.0100.010
Surprise %25.00%0.00%33.30%0.00%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.03-0.02-0.110.01
7 Days Ago-0.03-0.02-0.110.01
30 Days Ago-0.03-0.02-0.110.01
60 Days Ago-0.03-0.02-0.110.01
90 Days Ago-0.03-0.02-0.110.01
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesATRSIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.32
Next Qtr.33.30%N/AN/A0.39
Current Year31.20%N/AN/A0.15
Next Year109.10%N/AN/A0.12
Next 5 Years (per annum)78.90%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A